185 related articles for article (PubMed ID: 21549019)
1. Defective interfering virus protects elderly mice from influenza.
Scott PD; Meng B; Marriott AC; Easton AJ; Dimmock NJ
Virol J; 2011 May; 8():212. PubMed ID: 21549019
[TBL] [Abstract][Full Text] [Related]
2. Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus.
Scott PD; Meng B; Marriott AC; Easton AJ; Dimmock NJ
J Gen Virol; 2011 Sep; 92(Pt 9):2122-2132. PubMed ID: 21632569
[TBL] [Abstract][Full Text] [Related]
3. Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.
Scott PD; Meng B; Marriott AC; Easton AJ; Dimmock NJ
Vaccine; 2011 Sep; 29(38):6584-91. PubMed ID: 21762748
[TBL] [Abstract][Full Text] [Related]
4. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
Duhaut SD; Dimmock NJ
Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
[TBL] [Abstract][Full Text] [Related]
5. Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus.
Noble S; Dimmock NJ
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3485-91. PubMed ID: 7996140
[TBL] [Abstract][Full Text] [Related]
6. Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication.
Dimmock NJ; Beck S; McLain L
J Gen Virol; 1986 May; 67 ( Pt 5)():839-50. PubMed ID: 2422317
[TBL] [Abstract][Full Text] [Related]
7. Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established.
Dimmock NJ; Dove BK; Scott PD; Meng B; Taylor I; Cheung L; Hallis B; Marriott AC; Carroll MW; Easton AJ
PLoS One; 2012; 7(12):e49394. PubMed ID: 23251341
[TBL] [Abstract][Full Text] [Related]
8. A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo.
Easton AJ; Scott PD; Edworthy NL; Meng B; Marriott AC; Dimmock NJ
Vaccine; 2011 Mar; 29(15):2777-84. PubMed ID: 21320545
[TBL] [Abstract][Full Text] [Related]
9. Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing.
Noble S; McLain L; Dimmock NJ
Vaccine; 2004 Aug; 22(23-24):3018-25. PubMed ID: 15297051
[TBL] [Abstract][Full Text] [Related]
10. Influenza Defective Interfering Virus Promotes Multiciliated Cell Differentiation and Reduces the Inflammatory Response in Mice.
Wang C; Honce R; Salvatore M; Chow D; Randazzo D; Yang J; Twells NM; Mahal LK; Schultz-Cherry S; Ghedin E
J Virol; 2023 Jun; 97(6):e0049323. PubMed ID: 37255439
[TBL] [Abstract][Full Text] [Related]
11. A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral.
Smith CM; Scott PD; O'Callaghan C; Easton AJ; Dimmock NJ
Viruses; 2016 Aug; 8(8):. PubMed ID: 27556481
[TBL] [Abstract][Full Text] [Related]
12. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
[TBL] [Abstract][Full Text] [Related]
13. Protection of three strains of mice against lethal influenza in vivo by defective interfering virus.
Morgan DJ; McLain L; Dimmock NJ
Virus Res; 1993 Aug; 29(2):179-83. PubMed ID: 8212859
[TBL] [Abstract][Full Text] [Related]
14. Defective interfering influenza virus inhibits immunopathological effects of infectious virus in the mouse.
Morgan DJ; Dimmock NJ
J Virol; 1992 Feb; 66(2):1188-92. PubMed ID: 1731097
[TBL] [Abstract][Full Text] [Related]
15. The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses.
Pica N; Iyer A; Ramos I; Bouvier NM; Fernandez-Sesma A; García-Sastre A; Lowen AC; Palese P; Steel J
J Virol; 2011 Dec; 85(23):12825-9. PubMed ID: 21917963
[TBL] [Abstract][Full Text] [Related]
16. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
[TBL] [Abstract][Full Text] [Related]
17. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
[TBL] [Abstract][Full Text] [Related]
18. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral.
Dimmock NJ; Rainsford EW; Scott PD; Marriott AC
J Virol; 2008 Sep; 82(17):8570-8. PubMed ID: 18579602
[TBL] [Abstract][Full Text] [Related]
19. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
20. Dissemination of influenza B virus to the lower respiratory tract of mice is restricted by the interferon response.
Schwab LSU; Do THT; Pilapitiya D; Koutsakos M
J Virol; 2024 Jun; 98(6):e0160423. PubMed ID: 38780249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
